Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1Phase 4 1Phase 3 1

Status

Completed 3Withdrawn 1Terminated 1Suspended 1

Sponsor Class

OTHER 15INDUSTRY 6NIH 2OTHER_GOV 1

Study Type

Interventional 6

Sponsor

Cancer Type

Sarcoma 1

Conditions

Neoplasms 2875Carcinoma, Non-Small-Cell Lung 2428Breast Neoplasms 2068Colorectal Neoplasms 1247Neoplasm Metastasis 1232Prostatic Neoplasms 1080Melanoma 974Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 852Leukemia, Myeloid, Acute 810Lung Neoplasms 758Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 623Carcinoma, Hepatocellular 566Carcinoma, Renal Cell 546Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 468Head and Neck Neoplasms 451Glioblastoma 436Advanced Solid Tumors 432Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Interventions

resiniferatoxin 2Standard of Care 1Pregabalin 1Fentanyl 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Pain, Intractable × Clear all
NCT05067257 2024-03-18

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

Sorrento Therapeutics, Inc.

Phase 2 Suspended
120 enrolled

Cancer Pain, Pain, Pain, Intractable

NCT01854229 2023-10-18

Prometra Post-Approval Study

Flowonix Medical

Phase NA Completed
400 enrolled

Cancer Pain, Back Pain, Pain, Intractable, Chronic Pain

NCT04572776 2021-11-09

Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain

Sorrento Therapeutics, Inc.

Phase 3 Withdrawn

Cancer Pain, Pain, Pain, Intractable

NCT00381095 2021-01-20

COPE

Pfizer

Phase 4 Terminated
152 enrolled 14 charts
Sarcoma

Bone Neoplasms, Neoplasms, Pain, Intractable

NCT01291901 2014-08-08

NP2 Enkephalin For Treatment of Intractable Cancer Pain

Diamyd Inc

Phase 2 Completed
33 enrolled

Neoplasms, Pain, Pain, Intractable

NCT00216658 2011-01-24

Phase II Clinical Trial of Fentanyl Transdermal Matrix Patch, in the Management of Cancer Pain- Assessment of Effectiveness, Safety and Pharmacokinetics -

Janssen Pharmaceutical K.K.

Phase 2 Completed
87 enrolled

Cancer Pain, Pain, Intractable

Data powered by HemOnc (CC BY 4.0) Colophon âš¡